Moreover, two recent studies reported the development of novel dual HDAC and HSP90 inhibitors, where a single small molecule inhibited both HDAC and HSP90 that were tested on age-related macular degeneration [62] and leukemia [63]. The gene discussed is HDAC9; the disease is leukemia.